Stock Research: CONMED

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

CONMED

NasdaqGS:CNMD US2074101013
87
  • Value
    78
  • Growth
    25
  • Safety
    Safety
    98
  • Combined
    90
  • Sentiment
    63
  • 360° View
    360° View
    87
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

CONMED Corporation is a medical technology company that provides devices and equipment for surgical procedures. It operates in the medical technology industry, focusing on orthopedic and general surgery. CONMED's products are used by surgeons and healthcare professionals in various specialties. In the last fiscal year, the company had a market cap of $1,510 million, profits of $733 million, and revenue of $1,307 million, with 3900 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 87 (better than 87% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock CONMED are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for CONMED. The consolidated Value Rank has an attractive rank of 98, which means that the share price of CONMED is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 98% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 78. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 63. But the consolidated Growth Rank has a low rank of 25, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 75 of its competitors have better growth. ...read more

more
Index
Dividends USA
D.J. US Medical Equipment
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out
Learn More

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
98 99 67 75
Growth
25 51 79 53
Safety
Safety
78 80 1 15
Sentiment
63 39 56 46
360° View
360° View
87 95 54 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
5 33 37 48
Opinions Change
73 2 50 23
Pro Holdings
n/a 71 48 54
Market Pulse
91 87 86 81
Sentiment
63 39 56 46
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
98 99 67 75
Growth
25 51 79 53
Safety Safety
78 80 1 15
Combined
90 100 48 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
76 77 34 29
Price vs. Earnings (P/E)
75 68 56 63
Price vs. Book (P/B)
70 59 46 52
Dividend Yield
96 94 83 90
Value
98 99 67 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
25 34 44 35
Profit Growth
32 38 89 75
Capital Growth
61 76 39 25
Stock Returns
39 37 85 83
Growth
25 51 79 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
28 28 14 23
Refinancing
65 61 19 25
Liquidity
66 76 53 53
Safety Safety
78 80 1 15

Similar Stocks

Discover high‑ranked alternatives to CONMED and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.